EU red blood cell research project to advance rare anaemia patient care

November 14, 2013
EU red blood cell research project to advance rare anaemia patient care
Credit: Shutterstock

Anaemia is a condition in which your blood has a lower than normal number of red blood cells. It affects 1.6 billion people worldwide, with approximately 10 percent of these individuals suffering from a rare form of the disease. Concretely, the lack of haemoglobin in the blood slows down the delivery of oxygen from the respiratory organs to the rest of the body, resulting in less energy to power the functions of the patient's organism. In such scenarios, various symptoms occur including fatigue, weakness and difficulty concentrating. If the anaemia becomes more severe - particularly in rare anaemias - it can become life threatening.

The root causes of the approximately 90 different types of red blood cell diseases have not yet been adequately investigated. The link between the molecular causes and clinical symptoms in red blood cell diseases like and groups of inherited - thalassemia - is still poorly understood and appropriate treatments are often ineffective.

As a consequence, there is a high demand for new tools to improve diagnosis and monitor red blood cell disease progression. This is where COMMITMENT - a newly launched EU funded research project - comes into play. Over the next five years, the project is expected to develop reliable imaging technologies for therapy and personalised medication in rare anaemia treatments.

The innovative approach of the international research group, led by Dr Lars Kaestner, Head of the Centre for Molecular Imaging and Screening at Saarland University, Germany, is based on the combination of specific imaging technologies (molecular and functional imaging).

"The individual technologies, and to a larger extent the unique fusion of technologies, will allow for the identification and probing of the molecular players that underlie rare anaemia. In doing so, this innovative technology will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia. This will enable us to develop new (personalised) treatments for this group of established, emerging, and as yet undiscovered red blood cell disorders," explains Dr Kaestner.

Explore further: Enzyme 'Lyn' linked to anaemia

More information: www.rare-anaemia.eu/

Related Stories

Enzyme 'Lyn' linked to anaemia

August 21, 2013
New research by a team including experts from the UWA-affiliated Western Australian Institute for Medical Research (WAIMR) has proved a link between an enzyme known as "Lyn" and the blood disorder anaemia.

UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials

July 1, 2013
Researchers at UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients ...

Team creates a unique mouse model for the study of aplastic anaemia

August 29, 2012
Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most ...

Study identifies 75 genetic regions that influence red blood cell formation

December 5, 2012
New research is revealing how red blood cells are made and how the body regulates the amount of haemoglobin that is packaged in red blood cells at any time. Genomic analysis techniques have doubled the number of genetic regions ...

Recommended for you

Study shows wearable robotic exoskeletons improve walking for children with cerebral palsy

August 24, 2017
According to the Centers for Disease Control and Prevention, cerebral palsy (CP)—caused by neurological damage before, during or after birth—is the most common movement disorder in children, limiting mobility and independence ...

New understanding of how muscles work

August 23, 2017
Muscle malfunctions may be as simple as a slight strain after exercise or as serious as heart failure and muscular dystrophy. A new technique developed at McGill now makes it possible to look much more closely at how sarcomeres, ...

Scientists find RNA with special role in nerve healing process

August 22, 2017
Scientists may have identified a new opening to intervene in the process of healing peripheral nerve damage with the discovery that an "anti-sense" RNA (AS-RNA) is expressed when nerves are injured. Their experiments in mice ...

Mouse model of human immune system inadequate for stem cell studies

August 22, 2017
A type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a study by researchers at the Stanford University School ...

Researchers offer new targets for drugs against fatty liver disease and liver cancer

August 22, 2017
There may no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help scientists develop the most effective treatments. Researchers in Sweden have just identified a number of ...

Link between cells associated with aging and bone loss

August 21, 2017
Mayo Clinic researchers have reported a causal link between senescent cells - the cells associated with aging and age-related disease - and bone loss in mice. Targeting these cells led to an increase in bone mass and strength. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.